Effects of dexamethasone on ischemia reperfusion injury following pringle maneuver

Kerem Karaman1, M Bulent Tirnaksiz, Nuray Ulusu

  • 1Department of General Surgery, Hacettepe University Faculty of Medicine, Ankara, Turkey. keremkaraman1972@yahoo.com

Abstract

Insights

Low dose dexamethasone pretreatment effectively reduced bacterial translocation and apoptosis following Pringle maneuver. High dose dexamethasone showed partial benefits, indicating low-dose is more beneficial for hepatic ischemia reperfusion injury.

Area of Science:

  • Hepatology
  • Surgical Research
  • Pharmacology

Background:

  • Hepatic ischemia reperfusion injury (IRI) from the Pringle maneuver can cause bacterial translocation, endotoxemia, and apoptosis.
  • Investigating protective strategies against IRI is crucial for improving patient outcomes.

Purpose of the Study:

  • To compare the efficacy of low versus high dose dexamethasone pretreatment in mitigating IRI.
  • To evaluate the impact of dexamethasone on antioxidant enzyme activity, bacterial translocation, endotoxemia, and apoptosis.

Main Methods:

  • Thirty-two rats were divided into sham, control, low-dose dexamethasone (0.1 mg/kg), and high-dose dexamethasone (1 mg/kg) groups.
  • Dexamethasone was administered intraperitoneally one hour before the Pringle maneuver.
  • Bacterial translocation, endotoxemia, apoptosis, and antioxidant enzyme activities (G6PD, 6-PGD, GR, GST, GPx, CAT) were assessed 24 hours post-injury.

Main Results:

  • Low-dose dexamethasone significantly reduced bacterial translocation to mesenteric lymph nodes and decreased liver and enterocyte apoptosis.
  • High-dose dexamethasone primarily reduced enterocyte apoptosis.
  • Both low and high doses of dexamethasone significantly attenuated the reduction in antioxidant enzyme levels.

Conclusions:

  • Low-dose dexamethasone pretreatment demonstrated significant therapeutic benefits in reducing IRI complications.
  • High-dose dexamethasone offered partial protection, suggesting a dose-dependent effect.
  • Dexamethasone, particularly at low doses, may be a valuable therapeutic option for managing hepatic IRI.

Related Concept Videos